Literature DB >> 22350525

Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.

Russell O Bainer1, Jennifer Taylor Veneris2, S Diane Yamada3, Anthony Montag4, Mark W Lingen4, Yoav Gilad1, Carrie W Rinker-Schaeffer2.   

Abstract

Although metastasis is the most lethal attribute of cancer, critical gaps in our knowledge of how cancer cells effectively colonize distant sites remain. For example, little is known about the cellular and molecular events that occur during the timecourse of metastatic colonization. To address this we are using the mitogen-activated protein kinase kinase 4 (MKK4) metastasis suppressor as a tool to identify these events. Specifically, we report a microarray expression-based strategy to identify genes whose transcription is altered in SKOV3ip.1 human ovarian cancer cells that express ectopic MKK4 throughout the course of in vivo metastatic colonization. The majority of genes identified fell into the categories of cytokinesis, cytoskeleton remodeling, and cell adhesion, and their expression was repressed in MKK4-expressing cells relative to vector controls. The greatest transcriptional divergence was concomitant with impaired proliferation at 14 days post injection (dpi). Specifically, 763 genes were differentially expressed (FDR < 0.05) between lesions that expressed ectopic MKK4 and paired controls. In contrast, only seven genes were differentially expressed at the experimental endpoint, when MKK4-expressing and control cells had formed macroscopic metastases. Application of our cohort of differentially expressed genes to three independent clinical datasets demonstrated a strong correlation between our findings and metastatic phenotypes in patient samples. Our results highlight the dynamic nature of metastatic colonization and reinforce the importance of examining both molecular and cellular phenotypes over time when studying metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350525      PMCID: PMC4026167          DOI: 10.1007/s10585-011-9448-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  38 in total

1.  Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression.

Authors:  Horace DeLisser; Yong Liu; Pierre-Yves Desprez; Ann Thor; Paraskevei Briasouli; Chakrapong Handumrongkul; Jonathon Wilfong; Garret Yount; Mehdi Nosrati; Sylvia Fong; Emma Shtivelman; Melane Fehrenbach; Gaoyuan Cao; Dan H Moore; Shruti Nayak; Shruti Nyack; Denny Liggitt; Mohammed Kashani-Sabet; Robert Debs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-06       Impact factor: 11.205

2.  Normalization of cDNA microarray data.

Authors:  Gordon K Smyth; Terry Speed
Journal:  Methods       Date:  2003-12       Impact factor: 3.608

3.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Authors:  Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
Journal:  BMC Med Genomics       Date:  2008-04-28       Impact factor: 3.063

4.  Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Authors:  Neali D Hendrix; Rong Wu; Rork Kuick; Donald R Schwartz; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

5.  An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

Authors:  Holly K Dressman; Andrew Berchuck; Gina Chan; Jun Zhai; Andrea Bild; Robyn Sayer; Janiel Cragun; Jennifer Clarke; Regina S Whitaker; Lihua Li; Jonathan Gray; Jeffrey Marks; Geoffrey S Ginsburg; Anil Potti; Mike West; Joseph R Nevins; Johnathan M Lancaster
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

Review 6.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

7.  The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.

Authors:  Jonathan A Hickson; Dezheng Huo; Donald J Vander Griend; Anning Lin; Carrie W Rinker-Schaeffer; S Diane Yamada
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

8.  Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases.

Authors:  Ian D McGilvray; Vance Tsai; John C Marshall; Alan P B Dackiw; Ori D Rotstein
Journal:  Shock       Date:  2002-07       Impact factor: 3.454

9.  WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.

Authors:  Yutaka Matsuda; Thomas Schlange; Edward J Oakeley; Anne Boulay; Nancy E Hynes
Journal:  Breast Cancer Res       Date:  2009-05-27       Impact factor: 6.466

10.  Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway.

Authors:  Shun-Chi Wu; Shin C Chang; Hung-Yi Wu; Pei-Ju Liao; Ming-Fu Chang
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

View more
  1 in total

1.  Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Authors:  Rain R Chen; Mingo M H Yung; Yang Xuan; Shijie Zhan; Leanne L Leung; Rachel R Liang; Thomas H Y Leung; Huijuan Yang; Dakang Xu; Rakesh Sharma; Karen K L Chan; Siew-Fei Ngu; Hextan Y S Ngan; David W Chan
Journal:  Commun Biol       Date:  2019-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.